Bortezomib-based therapy for mantle-cell lymphoma

Comment

Franco Cavalli. N Engl J Med. 2015.

. 2015 Jun 4;372(23):2271.

doi: 10.1056/NEJMc1504240.

No abstract available

Comment on

Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.
Robak T, Huang H, Jin J, Zhu J, Liu T, Samoilova O, Pylypenko H, Verhoef G, Siritanaratkul N, Osmanov E, Alexeeva J, Pereira J, Drach J, Mayer J, Hong X, Okamoto R, Pei L, Rooney B, van de Velde H, Cavalli F; LYM-3002 Investigators. Robak T, et al. N Engl J Med. 2015 Mar 5;372(10):944-53. doi: 10.1056/NEJMoa1412096. N Engl J Med. 2015. PMID: 25738670 Clinical Trial.
Bortezomib-based therapy for mantle-cell lymphoma.
Baccarani M. Baccarani M. N Engl J Med. 2015 Jun 4;372(23):2270. doi: 10.1056/NEJMc1504240. N Engl J Med. 2015. PMID: 26039613 No abstract available.
Bortezomib-based therapy for mantle-cell lymphoma.
Sengar M, Jain H. Sengar M, et al. N Engl J Med. 2015 Jun 4;372(23):2270-1. doi: 10.1056/NEJMc1504240. N Engl J Med. 2015. PMID: 26039614 No abstract available.